Cargando…

A non-invasive diagnostic model of immunoglobulin A nephropathy and serological markers for evaluating disease severity

BACKGROUND: Immunoglobulin A nephropathy (IgAN) is the most common pathological type of glomerular disease. Kidney biopsy, the gold standard for IgAN diagnosis, has not been routinely applied in hospitals worldwide due to its invasion nature. Thus, we aim to establish a non-invasive diagnostic model...

Descripción completa

Detalles Bibliográficos
Autores principales: Han, Qiu-Xia, Wang, Yong, Zhu, Han-Yu, Zhang, Dong, Gao, Jing, Liu, Zhang-Suo, Cai, Guang-Yan, Chen, Xiang-Mei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6416104/
https://www.ncbi.nlm.nih.gov/pubmed/30855344
http://dx.doi.org/10.1097/CM9.0000000000000121
_version_ 1783403283118817280
author Han, Qiu-Xia
Wang, Yong
Zhu, Han-Yu
Zhang, Dong
Gao, Jing
Liu, Zhang-Suo
Cai, Guang-Yan
Chen, Xiang-Mei
author_facet Han, Qiu-Xia
Wang, Yong
Zhu, Han-Yu
Zhang, Dong
Gao, Jing
Liu, Zhang-Suo
Cai, Guang-Yan
Chen, Xiang-Mei
author_sort Han, Qiu-Xia
collection PubMed
description BACKGROUND: Immunoglobulin A nephropathy (IgAN) is the most common pathological type of glomerular disease. Kidney biopsy, the gold standard for IgAN diagnosis, has not been routinely applied in hospitals worldwide due to its invasion nature. Thus, we aim to establish a non-invasive diagnostic model and determine markers to evaluate disease severity by analyzing the serological parameters and pathological stages of patients with IgAN. METHODS: A total of 272 biopsy-diagnosed IgAN inpatients and 518 non-IgA nephropathy inpatients from the Department of Nephrology of Chinese People's Liberation Army General Hospital were recruited for this study. Routine blood examination, blood coagulation testing, immunoglobulin-complement testing, and clinical biochemistry testing were conducted and pathological stages were analyzed according to Lee grading system. The serological parameters and pathological stages were analyzed. The receiver operating characteristic (ROC) analysis was performed to estimate the diagnostic value of the clinical factors. Logistic regression was used to establish the diagnostic model. RESULTS: There were 15 significantly different serological parameters between the IgAN and non-IgAN groups (all P < 0.05). The ROC analysis was performed to measure the diagnostic value for IgAN of these parameters and the results showed that the area under the ROC curve (AUC) of total protein (TP), total cholesterol (TC), fibrinogen (FIB), D-dimer (D2), immunoglobulin A (IgA), and immunoglobulin G (IgG) were more than 0.70. The AUC of the “TC + FIB + D2 + IgA + age” combination was 0.86, with a sensitivity of 85.98% and a specificity of 73.85%. Pathological grades of I, II, III, IV, and V accounted for 2.21%, 17.65%, 62.50%, 11.76%, and 5.88%, respectively, with grade III being the most prevalent. The levels of urea nitrogen (UN) (13.57 ± 5.95 vs. 6.06 ± 3.63, 5.92 ± 2.97, 5.41 ± 1.73, and 8.41 ± 3.72 mmol/L, respectively) and creatinine (Cr) (292.19 ± 162.21 vs. 80.42 ± 24.75, 103.79 ± 72.72, 96.41 ± 33.79, and 163.04 ± 47.51 μmol/L, respectively) were significantly higher in grade V than in the other grades, and the levels of TP (64.45 ± 7.56, 67.16 ± 6.94, 63.22 ± 8.56, and 61.41 ± 10.86 vs. 37.47 ± 5.6 mg/d, respectively), direct bilirubin (DB) (2.34 ± 1.23, 2.58 ± 1.40, 1.91 ± 0.97, and 1.81 ± 1.44 vs. 0.74 ± 0.57 μmol/L, respectively), and IgA (310.35 ± 103.78, 318.48 ± 107.54, 292.58 ± 81.85, and 323.29 ± 181.67 vs. 227.17 ± 68.12 g/L, respectively) were significantly increased in grades II–V compared with grade I (all P < 0.05). CONCLUSIONS: The established diagnostic model that combined multiple factors (TC, FIB, D2, IgA, and age) might be used for IgAN non-invasive diagnosis. TP, DB, IgA, Cr, and UN have the potential to be used to evaluate IgAN disease severity.
format Online
Article
Text
id pubmed-6416104
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Wolters Kluwer Health
record_format MEDLINE/PubMed
spelling pubmed-64161042019-03-19 A non-invasive diagnostic model of immunoglobulin A nephropathy and serological markers for evaluating disease severity Han, Qiu-Xia Wang, Yong Zhu, Han-Yu Zhang, Dong Gao, Jing Liu, Zhang-Suo Cai, Guang-Yan Chen, Xiang-Mei Chin Med J (Engl) Original Articles BACKGROUND: Immunoglobulin A nephropathy (IgAN) is the most common pathological type of glomerular disease. Kidney biopsy, the gold standard for IgAN diagnosis, has not been routinely applied in hospitals worldwide due to its invasion nature. Thus, we aim to establish a non-invasive diagnostic model and determine markers to evaluate disease severity by analyzing the serological parameters and pathological stages of patients with IgAN. METHODS: A total of 272 biopsy-diagnosed IgAN inpatients and 518 non-IgA nephropathy inpatients from the Department of Nephrology of Chinese People's Liberation Army General Hospital were recruited for this study. Routine blood examination, blood coagulation testing, immunoglobulin-complement testing, and clinical biochemistry testing were conducted and pathological stages were analyzed according to Lee grading system. The serological parameters and pathological stages were analyzed. The receiver operating characteristic (ROC) analysis was performed to estimate the diagnostic value of the clinical factors. Logistic regression was used to establish the diagnostic model. RESULTS: There were 15 significantly different serological parameters between the IgAN and non-IgAN groups (all P < 0.05). The ROC analysis was performed to measure the diagnostic value for IgAN of these parameters and the results showed that the area under the ROC curve (AUC) of total protein (TP), total cholesterol (TC), fibrinogen (FIB), D-dimer (D2), immunoglobulin A (IgA), and immunoglobulin G (IgG) were more than 0.70. The AUC of the “TC + FIB + D2 + IgA + age” combination was 0.86, with a sensitivity of 85.98% and a specificity of 73.85%. Pathological grades of I, II, III, IV, and V accounted for 2.21%, 17.65%, 62.50%, 11.76%, and 5.88%, respectively, with grade III being the most prevalent. The levels of urea nitrogen (UN) (13.57 ± 5.95 vs. 6.06 ± 3.63, 5.92 ± 2.97, 5.41 ± 1.73, and 8.41 ± 3.72 mmol/L, respectively) and creatinine (Cr) (292.19 ± 162.21 vs. 80.42 ± 24.75, 103.79 ± 72.72, 96.41 ± 33.79, and 163.04 ± 47.51 μmol/L, respectively) were significantly higher in grade V than in the other grades, and the levels of TP (64.45 ± 7.56, 67.16 ± 6.94, 63.22 ± 8.56, and 61.41 ± 10.86 vs. 37.47 ± 5.6 mg/d, respectively), direct bilirubin (DB) (2.34 ± 1.23, 2.58 ± 1.40, 1.91 ± 0.97, and 1.81 ± 1.44 vs. 0.74 ± 0.57 μmol/L, respectively), and IgA (310.35 ± 103.78, 318.48 ± 107.54, 292.58 ± 81.85, and 323.29 ± 181.67 vs. 227.17 ± 68.12 g/L, respectively) were significantly increased in grades II–V compared with grade I (all P < 0.05). CONCLUSIONS: The established diagnostic model that combined multiple factors (TC, FIB, D2, IgA, and age) might be used for IgAN non-invasive diagnosis. TP, DB, IgA, Cr, and UN have the potential to be used to evaluate IgAN disease severity. Wolters Kluwer Health 2019-03-20 2019-03-20 /pmc/articles/PMC6416104/ /pubmed/30855344 http://dx.doi.org/10.1097/CM9.0000000000000121 Text en Copyright © 2019 The Chinese Medical Association, produced by Wolters Kluwer, Inc. under the CC-BY-NC-ND license. http://creativecommons.org/licenses/by-nc-nd/4.0 This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc-nd/4.0
spellingShingle Original Articles
Han, Qiu-Xia
Wang, Yong
Zhu, Han-Yu
Zhang, Dong
Gao, Jing
Liu, Zhang-Suo
Cai, Guang-Yan
Chen, Xiang-Mei
A non-invasive diagnostic model of immunoglobulin A nephropathy and serological markers for evaluating disease severity
title A non-invasive diagnostic model of immunoglobulin A nephropathy and serological markers for evaluating disease severity
title_full A non-invasive diagnostic model of immunoglobulin A nephropathy and serological markers for evaluating disease severity
title_fullStr A non-invasive diagnostic model of immunoglobulin A nephropathy and serological markers for evaluating disease severity
title_full_unstemmed A non-invasive diagnostic model of immunoglobulin A nephropathy and serological markers for evaluating disease severity
title_short A non-invasive diagnostic model of immunoglobulin A nephropathy and serological markers for evaluating disease severity
title_sort non-invasive diagnostic model of immunoglobulin a nephropathy and serological markers for evaluating disease severity
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6416104/
https://www.ncbi.nlm.nih.gov/pubmed/30855344
http://dx.doi.org/10.1097/CM9.0000000000000121
work_keys_str_mv AT hanqiuxia anoninvasivediagnosticmodelofimmunoglobulinanephropathyandserologicalmarkersforevaluatingdiseaseseverity
AT wangyong anoninvasivediagnosticmodelofimmunoglobulinanephropathyandserologicalmarkersforevaluatingdiseaseseverity
AT zhuhanyu anoninvasivediagnosticmodelofimmunoglobulinanephropathyandserologicalmarkersforevaluatingdiseaseseverity
AT zhangdong anoninvasivediagnosticmodelofimmunoglobulinanephropathyandserologicalmarkersforevaluatingdiseaseseverity
AT gaojing anoninvasivediagnosticmodelofimmunoglobulinanephropathyandserologicalmarkersforevaluatingdiseaseseverity
AT liuzhangsuo anoninvasivediagnosticmodelofimmunoglobulinanephropathyandserologicalmarkersforevaluatingdiseaseseverity
AT caiguangyan anoninvasivediagnosticmodelofimmunoglobulinanephropathyandserologicalmarkersforevaluatingdiseaseseverity
AT chenxiangmei anoninvasivediagnosticmodelofimmunoglobulinanephropathyandserologicalmarkersforevaluatingdiseaseseverity
AT hanqiuxia noninvasivediagnosticmodelofimmunoglobulinanephropathyandserologicalmarkersforevaluatingdiseaseseverity
AT wangyong noninvasivediagnosticmodelofimmunoglobulinanephropathyandserologicalmarkersforevaluatingdiseaseseverity
AT zhuhanyu noninvasivediagnosticmodelofimmunoglobulinanephropathyandserologicalmarkersforevaluatingdiseaseseverity
AT zhangdong noninvasivediagnosticmodelofimmunoglobulinanephropathyandserologicalmarkersforevaluatingdiseaseseverity
AT gaojing noninvasivediagnosticmodelofimmunoglobulinanephropathyandserologicalmarkersforevaluatingdiseaseseverity
AT liuzhangsuo noninvasivediagnosticmodelofimmunoglobulinanephropathyandserologicalmarkersforevaluatingdiseaseseverity
AT caiguangyan noninvasivediagnosticmodelofimmunoglobulinanephropathyandserologicalmarkersforevaluatingdiseaseseverity
AT chenxiangmei noninvasivediagnosticmodelofimmunoglobulinanephropathyandserologicalmarkersforevaluatingdiseaseseverity